BH4
Version 1.0, 2018/03/21
Approved small_molecule active
Quick answer
BH4 for Pku Phenylketonuria is a Approved program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Pku Phenylketonuria
- Phase
- Approved
- Modality
- small_molecule
- Status
- active